KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Total Current Liabilities: 2018-2025

Historic Total Current Liabilities for Twist Bioscience (TWST) over the last 7 years, with Sep 2025 value amounting to $91.4 million.

  • Twist Bioscience's Total Current Liabilities rose 28.73% to $91.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.4 million, marking a year-over-year increase of 28.73%. This contributed to the annual value of $91.4 million for FY2025, which is 28.73% up from last year.
  • According to the latest figures from Q3 2025, Twist Bioscience's Total Current Liabilities is $91.4 million, which was up 4.98% from $87.1 million recorded in Q2 2025.
  • Twist Bioscience's 5-year Total Current Liabilities high stood at $92.7 million for Q2 2022, and its period low was $40.4 million during Q1 2021.
  • In the last 3 years, Twist Bioscience's Total Current Liabilities had a median value of $72.8 million in 2023 and averaged $74.4 million.
  • As far as peak fluctuations go, Twist Bioscience's Total Current Liabilities surged by 115.71% in 2021, and later decreased by 22.20% in 2023.
  • Twist Bioscience's Total Current Liabilities (Quarterly) stood at $80.0 million in 2021, then rose by 4.75% to $83.8 million in 2022, then decreased by 22.20% to $65.2 million in 2023, then grew by 6.77% to $69.6 million in 2024, then climbed by 28.73% to $91.4 million in 2025.
  • Its last three reported values are $91.4 million in Q3 2025, $87.1 million for Q2 2025, and $75.0 million during Q1 2025.